Religious, spiritual statements during ICU goals-of-care discussions important
the ONA take:
Among a cohort of surrogate decision makers who view religion or spirituality as an important consideration near the end of life of the patient, discussion of religious or spiritual considerations occurred in fewer than 20% of goals-of-care conferences in intensive care units, according to a new study published online ahead of print in JAMA Internal Medicine.
For the study, researchers at the Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center at the University of Pittsburgh School of Medicine in Pittsburgh, PA, sought to determine how often healthcare professionals and surrogate decision makers discuss religious or spiritual considerations during family meetings.
Researchers analyzed data from 249 goals-of-care conversations conducted between 651 surrogate decision makers and 441 health care professionals in institutions across the United States. Results showed that only 16.1% of the 249 conversations included discussion of religious or spiritual considerations.
Researchers found that in 15 conversations, health care professionals redirected religious or spiritual conversations to medical considerations, and in only 8 conversations did health care professionals ask further questions regarding the patient or family's beliefs.
Discussion of religious or spiritual considerations occurred in fewer than 20% of goals-of-care conferences in intensive care units.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|